Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-08-000035
Filing Date
2008-07-02
Accepted
2008-07-02 19:17:36
Documents
1
Period of Report
2008-07-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 4215
  Complete submission text file 0000874015-08-000035.txt   6029
Mailing Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 1896 RUTHERFORD ROAD CARLSBAD CA 92008 7609319200
ISIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address 812-856-1840
DiMarchi Richard D (Reporting) CIK: 0001311733 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 08936094